Ductal adenocarcinoma is the most common primary malignancy of the pancreas, accounting for about 80% of malignant pancreatic tumors. It is a highly aggressive tumor with an overall 5-year survival rate less than 5%. Prognosis and treatment depend on whether the tumor is resectable or non-resectable, which mostly depends on the time of diagnosis

Ductal Adenocarcinoma

Mirko D’Onofrio
;
Riccardo De Robertis
;
Alessandro Beleù;Luca Geraci
;
Luisa Tomaiuolo
;
Giovanni Morana
;
2022-01-01

Abstract

Ductal adenocarcinoma is the most common primary malignancy of the pancreas, accounting for about 80% of malignant pancreatic tumors. It is a highly aggressive tumor with an overall 5-year survival rate less than 5%. Prognosis and treatment depend on whether the tumor is resectable or non-resectable, which mostly depends on the time of diagnosis
978-3-031-09830-7
Chronic pancreatitis, Pancreatic adenocarcinoma, Main pancreatic duct, Pancreatic ductal adenocarcinoma, Acoustic radiation force impulse
File in questo prodotto:
File Dimensione Formato  
indice_ Imaging and Pathology of Pancreatic Neoplasms.pdf

accesso aperto

Descrizione: indice_atlas
Licenza: Dominio pubblico
Dimensione 231.8 kB
Formato Adobe PDF
231.8 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1081893
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact